UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole

Alimentary pharmacology & therapeutics, 1998-10, Vol.12 (10), p.1027-1032

1998

Volltextzugriff (PDF)

Twenty‐four‐hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole

Alimentary pharmacology & therapeutics, 1996-06, Vol.10 (3), p.359-366

1996

Volltextzugriff (PDF)

Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation

Pharmaceutical research, 1994, Vol.11 (1), p.151-155

1994

Volltextzugriff (PDF)

Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man

European journal of clinical pharmacology, 1996, Vol.51 (3-4), p.277-281

1996

Volltextzugriff (PDF)

Optimizing the Absorption of Valspodar, a P-glycoprotein Modulator, Part I: Selecting an Oral Formulation and Exploring its Clinical Pharmacokinetics/Dynamics

Journal of clinical pharmacology, 1997-11, Vol.37 (11), p.1001-1008

1997

Volltextzugriff (PDF)

Pharmacokinetics of Acetazolamide in Healthy Volunteers after Short- and Long-Term Exposure to High Altitude

Journal of clinical pharmacology, 1998-06, Vol.38 (6), p.533-539

1998

Volltextzugriff (PDF)

Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve

Digestion, 1995, Vol.56 (6), p.493-501

1995

Volltextzugriff (PDF)

Influence of cholestyramine on the pharmacokinetics of cerivastatin

International journal of clinical pharmacology and therapeutics, 1997-06, Vol.35 (6), p.250

1997

Volltextzugriff (PDF)

Effect of buffering on pharmacokinetics of ketoprofen enantiomers in man

British journal of clinical pharmacology, 1997-12, Vol.44 (6), p.527-530

1997

Volltextzugriff (PDF)

Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine

Methods and Findings in Experimental and Clinical Pharmacology, 2005, Vol.27 (1), p.25-29

2005

Volltextzugriff (PDF)

A new method for the determination of the bioavailability of thyroid hormone preparations

Methods and findings in experimental and clinical pharmacology, 1994-03, Vol.16 (2), p.133

1994

Volltextzugriff (PDF)

Concomitant administration of the α-glucosidase inhibitor voglibose (AO-128) does not alter the pharmacokinetics of glibenclamide

European journal of clinical pharmacology, 1997, Vol.53 (2), p.149-152

1997

Volltextzugriff (PDF)

Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers

Methods and findings in experimental and clinical pharmacology, 1994-11, Vol.16 (9), p.651

1994

Volltextzugriff (PDF)

Relative bioavailability and bioequivalence of a newly developed fixed combination sachet of acetylsalicylic acid and pseudoephedrine compared with a preliminary combination

Methods and Findings in Experimental and Clinical Pharmacology, 2003-10, Vol.25 (8), p.631-637

2003

Volltextzugriff (PDF)

Bioequivalence of two commercially available tamoxifen tablet formulations in healthy male volunteers

Methods and findings in experimental and clinical pharmacology, 1994-07, Vol.16 (6), p.443

1994

Volltextzugriff (PDF)

Pharmacokinetics of Meperidine in Healthy Volunteers after Short- and Long-Term Exposure to High Altitude

Journal of clinical pharmacology, 1996-07, Vol.36 (7), p.610-616

1996

Volltextzugriff (PDF)

The α-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarin

European journal of clinical pharmacology, 1997, Vol.53 (2), p.153-157

1997

Volltextzugriff (PDF)

Comparison of the pharmacodynamics and pharmacokinetics of pantoprazole (40 mg) as compared to omeprazole MUPS (20 mg) after repeated oral dose administration

Methods and Findings in Experimental and Clinical Pharmacology, 1999, Vol.21 (1), p.47-51

1999

Volltextzugriff (PDF)

Bioavailability of a crushed pantoprazole tablet after buffering with sodium hydrogencarbonate or magaldrate relative to the intact enteric coated pantoprazole tablet

Methods and Findings in Experimental and Clinical Pharmacology, 2001, Vol.23 (1), p.41-45

2001

Volltextzugriff (PDF)

Dialysability of dimethindene maleate (Fenistil) from blood after intravenous injection

Methods and findings in experimental and clinical pharmacology, 1992-04, Vol.14 (3), p.225

1992

Volltextzugriff (PDF)

Anti-Inflammatory Activity of a Pyrrolizidine Alkaloid-Free Extract of Roots of Symphytum officinale in Humans

Planta medica, 1993-12, Vol.59 (S 1), p.A703-A704

1993

Volltextzugriff (PDF)

Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans

Antimicrobial Agents and Chemotherapy, 1987-12, Vol.31 (12), p.1909-1914

1987

Volltextzugriff (PDF)

A pilot study on the determination of the relative bioavailability of levo-thyroxine

Methods and findings in experimental and clinical pharmacology, 1995-06, Vol.17 (5), p.333

1995

Volltextzugriff (PDF)

Pharmacokinetics and relative bioavailability of a new chewable, buffered acetylsalicylic acid tablet formulation in comparison to a conventional plain tablet

Methods and findings in experimental and clinical pharmacology, 1992-12, Vol.14 (10), p.805

1992

Volltextzugriff (PDF)

Effect of processed and non-processed coffee samples on gastric potential difference. Study with healthy male Helicobacter pylori-positive and Helicobacter pylori-negative volunteers

Arzneimittel-Forschung, 1999-07, Vol.49 (7), p.626

1999

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Englisch
(100)
Deutsch
(48)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole

Twenty‐four‐hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole

Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation

Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man

Optimizing the Absorption of Valspodar, a P-glycoprotein Modulator, Part I: Selecting an Oral Formulation and Exploring its Clinical Pharmacokinetics/Dynamics

Pharmacokinetics of Acetazolamide in Healthy Volunteers after Short- and Long-Term Exposure to High Altitude

Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve

Influence of cholestyramine on the pharmacokinetics of cerivastatin

Effect of buffering on pharmacokinetics of ketoprofen enantiomers in man

Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine

A new method for the determination of the bioavailability of thyroid hormone preparations

Concomitant administration of the α-glucosidase inhibitor voglibose (AO-128) does not alter the pharmacokinetics of glibenclamide

Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers

Relative bioavailability and bioequivalence of a newly developed fixed combination sachet of acetylsalicylic acid and pseudoephedrine compared with a preliminary combination

Bioequivalence of two commercially available tamoxifen tablet formulations in healthy male volunteers

Pharmacokinetics of Meperidine in Healthy Volunteers after Short- and Long-Term Exposure to High Altitude

The α-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarin

Comparison of the pharmacodynamics and pharmacokinetics of pantoprazole (40 mg) as compared to omeprazole MUPS (20 mg) after repeated oral dose administration

Bioavailability of a crushed pantoprazole tablet after buffering with sodium hydrogencarbonate or magaldrate relative to the intact enteric coated pantoprazole tablet

Dialysability of dimethindene maleate (Fenistil) from blood after intravenous injection

Anti-Inflammatory Activity of a Pyrrolizidine Alkaloid-Free Extract of Roots of Symphytum officinale in Humans

Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans

A pilot study on the determination of the relative bioavailability of levo-thyroxine

Pharmacokinetics and relative bioavailability of a new chewable, buffered acetylsalicylic acid tablet formulation in comparison to a conventional plain tablet

Effect of processed and non-processed coffee samples on gastric potential difference. Study with healthy male Helicobacter pylori-positive and Helicobacter pylori-negative volunteers

Suchergebnisse filtern